Previous close | 73.35 |
Open | N/A |
Bid | 93.80 |
Ask | 102.50 |
Strike | 755.00 |
Expiry date | 2023-08-18 |
Day's range | 73.35 - 73.35 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Pipelines updates from Viking Therapeutics (VKTX) and Intra-Cellular (ITCI) are the key highlights for the biotech sector.
Regeneron Pharmaceuticals (REGN) has been a bright spot in the market lately.
Unity's (UBX) phase II ENVISION study on UBX1325 fails to meet the non-inferiority threshold compared to aflibercept through 24 weeks in the wet AMD study.